Atlas Trials

Real-world Studies of CDK4/6 Inhibitors

Clinical trial NCT07407439 · RECRUITING

Trial details

NCT number
NCT07407439
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2025-06-01
Primary completion
2026-06-01
Enrollment
245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.